CD38 and triple-A syndrome: Furthermore, we observed that Oss-128167, an SIRT6 inhibitor, partially eliminated the protective role of CD38SKO in the phenotype switch of AngII-mediated AAA, suggesting that the CD38-deficiency-mediated protective effects in AngII-induced AAA may be related to the NAD+/Sirt6 signaling pathway.